Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
| NCT01211002 | Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 4 | 170 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Sep 29, 2010 | clinicaltrials |
| NCT01211015 | Endoplasmic Reticulum Stress in Chronic Respiratory Diseases | unknown | — | 50 | Chonbuk National UniversityOTHER | 1 | Sep 29, 2010 | clinicaltrials |
| NCT01210053 | Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | Third Military Medical UniversityOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT00315185 | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | completed | Phase 2 | 53 | Fox Chase Cancer CenterOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT01192230 | Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00925210 | Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach | completed | Phase 2 | 60 | University of CalgaryOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT01201044 | Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)(DO201001) | unknown | N/A | 80 | Third Military Medical UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 3 | Sep 9, 2010 | clinicaltrials |
| NCT01192243 | Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Sep 3, 2010 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT00329472 | Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 0 | Aug 27, 2010 | clinicaltrials |
| NCT00544960 | A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 27, 2010 | clinicaltrials |
| NCT00397293 | Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 24, 2010 | clinicaltrials |
| NCT01187290 | Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | unknown | Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 24, 2010 | clinicaltrials |
| NCT00440414 | Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 320 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00074204 | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 3 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00831909 | Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN(EPICLIN) | completed | — | 3,513 | AstraZenecaINDUSTRY | 8 | Aug 10, 2010 | clinicaltrials |
| NCT01178190 | The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer(NBI) | completed | — | 101 | Asan Medical CenterOTHER | 1 | Aug 10, 2010 | clinicaltrials |
| NCT00255775 | Broccoli Sprout Extract in Preventing Lung Cancer in Smokers | completed | N/A | 70 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00276588 | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 46 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00673569 | Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | completed | Phase 2 | 40 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT01058785 | Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer | completed | Phase 2 | 75 | NovaRx CorporationINDUSTRY | 1 | Jul 29, 2010 | clinicaltrials |
| NCT01163058 | Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer | unknown | — | 300 | Istituto Clinico HumanitasOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00193362 | Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer | completed | Phase 3 | 200 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00193388 | Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00193401 | Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT01170923 | FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 100 | Asan Medical CenterOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00572325 | Concurrent Chemo-radiation Form NSCLC to a Individualized MLD(BRONC CONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00573040 | Radiotherapy for NSCLC to a Individualized MLD(BRONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00797238 | DNA Repair Genes and Outcomes in Patients With Stage III NSCLC | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Jul 15, 2010 | clinicaltrials |
| NCT00452803 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 102 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00453167 | Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer | completed | Phase 2 | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT01158144 | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) | unknown | Phase 2 | 134 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT01158170 | Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) | unknown | Phase 3 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00004225 | Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00193245 | Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193323 | Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients | completed | Phase 2 | 346 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00193349 | Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | Jun 28, 2010 | clinicaltrials |
| NCT00294931 | Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00308529 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT01145924 | Transbronchial Needle Forceps for Endobronchial Ultrasound | unknown | Phase 2 | 50 | Heidelberg UniversityOTHER | 1 | Jun 17, 2010 | clinicaltrials |
| NCT00783471 | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)(DOPERLO) | terminated | Phase 2 | 51 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT00003154 | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00006017 | Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00053300 | Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT01140958 | A Retrospective Pharmacoeconomic Study of Lung Cancer | unknown | — | 91 | Taipei Medical University WanFang HospitalOTHER | 0 | Jun 10, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Oct 4, 2010source: clinicaltrials